DETRALEX

This brand name is authorized in Estonia, Croatia, Lithuania, Romania

Active ingredients

The drug DETRALEX contains a combination of these active pharmaceutical ingredients (APIs):

1 Diosmin UNII 7QM776WJ5N - DIOSMIN

Diosmin (diosmetin 7-O-rutinoside), a flavone derivative also known as venosmine, is a glycoside of diosmetin, which in turn is the 4'-methoxy derivative of luteolin. Diosmin prolongs the vasoconstrictor effect of norepinephrine on the vein wall, increasing venous tone, and therefore reducing venous capacitance, distensibility, and venous stasis. This increases the venous return and reduces venous hyperpressure present in patients suffering from CVI. Read about Diosmin

2 Hesperidin UNII E750O06Y6O - HESPERIDIN

Read about Hesperidin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C05CA53	Diosmin, combinations	C Cardiovascular system → C05 Vasoprotectives → C05C Capillary stabilizing agents → C05CA Bioflavonoids
Discover more medicines within C05CA53

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1096949, 1609848
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-607242204, HR-H-639382683
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1009932, 1036152, 1056800, 1068713, 1071237, 1075576, 1089056, 1089057, 1089058
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W11615001, W11615002, W11615003, W11615004, W11615005, W11615006, W66812001, W66812002, W66812003, W66812004